| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 07/09/2009 | US20090176838 Cyclourea Compounds as Calcium Channel Blockers |
| 07/09/2009 | US20090176837 Compounds with activity at retinoic acid receptors |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | US20090176766 Imidazolidinone and imidazolidinethione derivatives |
| 07/09/2009 | US20090176716 Inhibitors of cancer cell, t-cell and keratinocyte proliferation |
| 07/09/2009 | DE102007059314A1 Verfahren zur Herstellung von Vorläufern für L-2-[18F]Fluor-phenylalanin und -[18F]Fluor-L-meta-tyrosin und deren α-methylierten Derivaten, Vorläufer, so e Verfahren zur Herstellung von L-2-[18F]Fluor-phenylalanin und 6-[18F]Fluor L-meta-tyrosin und deren α-methylierten Derivaten aus dem Vorläufer Process for the preparation of precursors for L-2- [18F] fluoro-phenylalanine and - [18F] fluoro-L-meta-tyrosine and the α-methylated derivatives, precursors, as e process for the preparation of L-2- [18F] fluoro-phenylalanine and 6- [18F] fluoro-L meta-tyrosine and the α-methylated derivatives from the precursor |
| 07/09/2009 | CA2710959A1 Imidazole carbonyl compounds and use thereof for treating bacterial infections |
| 07/08/2009 | EP2076497A1 Aminomethyl-4-imidazoles |
| 07/08/2009 | EP2076496A1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors |
| 07/08/2009 | EP2076489A1 Arylsulfonamidyl tetralin derivatives and uses thereof |
| 07/08/2009 | EP2076261A2 Muscarinic receptor antagonists |
| 07/08/2009 | EP1723118B1 Method for the production of ionic fluids the cation of which comprises a quaternary sp2 - hybridised nitrogen atom |
| 07/08/2009 | CN101479238A Amine derivative having npyy5 receptor antagonist activity |
| 07/08/2009 | CN100510091C Overcoming DAPA aminotransferase bottlenecks in biotin vitamers |
| 07/08/2009 | CN100509801C HIV inhibiting pyrimidines derivatives |
| 07/08/2009 | CN100509779C Dithiocarbamate |
| 07/07/2009 | CA2368165C Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 07/07/2009 | CA2345353C Null igf for the treatment of cancer |
| 07/02/2009 | WO2009082347A1 Bis- (sulf onylamino) derivatives for use in therapy |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009080523A1 Substituted hydantoins as mek kinase inhibitors |
| 07/02/2009 | WO2009080513A1 Permanently free-flowing ethylene urea |
| 07/02/2009 | US20090171098 Heteroaryl Salts and Methods For Producing and Using the Same |
| 07/02/2009 | US20090170824 Diarylsulfones as 5-HT2A Antagonists |
| 07/02/2009 | US20090170734 Novel imidazolinium salts with low melting point, processes for preparation thereof and use thereof as a lubricant |
| 07/02/2009 | DE102007063149A1 Neuartige Imidazolinium-Salze mit niedrigem Schmelzpunkt, Verfahren zu deren Herstellung und deren Verwendung als Schmiermittel Novel imidazolinium salts having a low melting point, to processes for their preparation and their use as lubricant |
| 07/02/2009 | CA2709510A1 Bis-(sulfonylamino) derivatives for use in therapy |
| 07/02/2009 | CA2707650A1 Substituted hydantoins as mek kinase inhibitors |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/01/2009 | EP2075229A1 Method for purifying fluorine compound |
| 07/01/2009 | EP2074102A1 2-phenyl indene derivatives useful as estrogen receptor ligands |
| 07/01/2009 | EP2074083A1 New sulfonamide derivatives as bradykinin antagonists |
| 07/01/2009 | EP1301486B1 Imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 07/01/2009 | EP1268371A4 Novel late transition metal catalyst complexes and oligomers therefrom |
| 07/01/2009 | CN101468969A Photoresponse ion liquid and preparation thereof |
| 07/01/2009 | CN101468968A Imidazolinum salts with low melting points, method for their manufacture and their use as lubricant |
| 07/01/2009 | CN100507563C N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination |
| 07/01/2009 | CN100506805C Process for producing 5-substituted oxa zole compounds and 5-substituted imidazole compounds |
| 07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
| 06/30/2009 | US7553976 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 06/30/2009 | US7553975 2-(((2-amino-1-oxo-3-mercapto-propyl)-amino)-methyl)-5-phenyl-thiazole-4-carbonyl-methionine; useful for treating restenosis or tissue proliferative diseases |
| 06/30/2009 | US7553972 Benzamide inhibitors of the P2X7 receptor |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553862 (Rac)-4-benzylamino-1-(3,4-dichloro-phenyl)-5-p-tolyl-1,5-dihydro-imidazol-2-one; glycine transport inhibitors; schizophrenia; Alzheimers' disease; dementia |
| 06/25/2009 | WO2009079624A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
| 06/25/2009 | WO2009079597A1 Piperazinyl derivatives useful as modulators of the neuropeptide y2 receptor |
| 06/25/2009 | WO2009077452A1 Method for improving the hydrolysis stability of ionic liquids |
| 06/25/2009 | WO2009077448A1 Kinesin inhibitors as cancer therapeutics |
| 06/25/2009 | WO2009077391A1 Azomethine direct dyes or reduced precursors of azomethine direct dyes obtained from 2-alkylresorcinols, and hair dyeing process using these dyes or precursors |
| 06/25/2009 | WO2009077365A1 Novel imidazole-substituted arylamides |
| 06/25/2009 | WO2009061744A3 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases |
| 06/25/2009 | WO2009041705A3 5-membered heterocyclic compounds as proton pump inhibitors |
| 06/25/2009 | US20090163566 Imidazole Derivatives and their use for Modulating the Gabaa Receptor Complex |
| 06/25/2009 | US20090163549 Pharmaceutical Composition Comprising an Amide Derivative |
| 06/25/2009 | US20090163496 Antibacterial agents |
| 06/25/2009 | US20090162420 Matrix-Controlled Transdermal System Comprising Salts of ACE Inhibitor Dicarboxylic Acids |
| 06/25/2009 | CA2709186A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
| 06/25/2009 | CA2708822A1 Kinesin inhibitors as cancer therapeutics |
| 06/25/2009 | CA2708791A1 Novel imidazole-substituted arylamides |
| 06/24/2009 | EP2072496A1 Method for producing high-purity quaternary ammonium salt |
| 06/24/2009 | CN101466686A C-FMS kinase inhibitor |
| 06/24/2009 | CN101466685A Enzyme inhibitors |
| 06/24/2009 | CN101463010A Non-ligand simple copper compound catalyzed N-arylation method under mild condition |
| 06/24/2009 | CN101463009A Method for synthesizing phentolamine mesylate |
| 06/24/2009 | CN100503600C Pesticidal heterocycles |
| 06/24/2009 | CN100503560C Substituted cyclohexane derivatives |
| 06/23/2009 | USRE40795 Pesticides, drugs, fungicides; reacting p-toluenesulfony isocyanate with phosphorus oxychloride or phosgene in presence of phase transfer agent and base; final stable solution without irritating, nonexplosive |
| 06/23/2009 | US7550497 sulfonamidophosphonate-functional heteroaryl compounds that contain SO2-NH-P(O)(-OR)2 group; antiinflammatory and analgesics; e.g. N-[4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]phenylsulfonyl]phosphoramidic acid; injectable COX-2 inhibitors |
| 06/23/2009 | US7550496 Hypoxia-activated prodrugs of alkylating agents such as of cyclophosphamide, ifosfamide, melphalan, chlorambucil, thiotepa; protected with 2-nitroimidazolyl group; targeted cancer cells more effectively, side effect reduction |
| 06/23/2009 | US7550491 Ionic liquids having [N(CF3)2]− anions |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | CA2420694C Guanidinobenzamides as mc4-r agonists |
| 06/23/2009 | CA2331396C Method for stabilizing unsaturated organic compounds from polymerization |
| 06/18/2009 | WO2009076258A1 Environmentally friendly bis-quaternary compounds for inhibiting corrosion and removing hydrocarbonaceous deposits in oil and gas applications |
| 06/18/2009 | WO2009075080A1 Fluoroalkylsulfide derivative and pest control agent |
| 06/18/2009 | WO2009074703A1 Deuterated tapazole and derivatives, preparation method therefor and use of same |
| 06/18/2009 | WO2009074538A1 Method for reprocessing mixtures containing imidazolium salts |
| 06/18/2009 | WO2009074535A2 Method for the production of disubstituted imidazolium salts |
| 06/18/2009 | US20090156830 Substituted Imidazoline Compounds |
| 06/18/2009 | US20090156619 Heterocycle Substituted Amide and Sulfur Amide Derivatives as Histone Deacetylase (HDAC) Inhibitors |
| 06/18/2009 | US20090156616 Therapeutic agents |
| 06/18/2009 | DE102007059313A1 Verfahren zur Herstellung von Vorläufern für L-3,4-Dihydroxy-6-[18F]fluor-phenylalanin und 2-[18F]Fluor-L-tyrosin und deren α-methylierten Derivaten, Vorläufer, sowie Verfahren zur Herstellung von L-3,4-Dihydroxy-6-[18F]fluor-phenylalanin und 2-[18F]Fluor-L-tyrosin und deren α-methylierten Derivaten aus dem Vorläufer Process for the preparation of precursors for L-3,4-dihydroxy-6- [18F] fluoro-phenylalanine and 2- [18F] fluoro-L-tyrosine and the α-methylated derivatives, precursors, as well as methods for the production of L-3 , 4-dihydroxy-6- [18F] fluoro-phenylalanine and 2- [18F] fluoro-L-tyrosine and the α-methylated derivatives from the precursor |
| 06/17/2009 | EP2071008A1 Lubricating composition comprising an imidazolidinethione and an imidazolidone |
| 06/17/2009 | EP2069280A2 Process and intermediates for preparing integrase inhibitors |
| 06/17/2009 | EP1472230B1 Ansamycins having improved pharmacological and biological properties |
| 06/17/2009 | CN101460467A Diarylthiohydantoin compounds |
| 06/17/2009 | CN101456844A Room temperature ion liquid containing sulfonic acid ester base side chain as well as preparation method and use thereof |
| 06/16/2009 | US7547800 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
| 06/16/2009 | US7547791 One-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1H-imidazole-1-yl)methyl]-4H-carbazol-4-O |
| 06/16/2009 | US7547717 2-thioxo-4-imidazolines; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 06/16/2009 | US7547711 Heterocyclic inhibitors of kinases |
| 06/16/2009 | CA2452217C Hiv inhibiting pyrimidines derivatives |
| 06/11/2009 | WO2009071584A1 Process for the preparation of 5-(2-ethyl-dihydro-1h-inden-2-yl)-1h-imidazole and salts thereof |
| 06/11/2009 | WO2009055053A3 Diarylhydantoin compounds as androgen receptor modulators |
| 06/11/2009 | WO2009051718A3 Calcium receptor modulating agents |
| 06/11/2009 | WO2008046758A3 Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes |
| 06/11/2009 | US20090149658 Novel Histidine Derivatives |
| 06/11/2009 | US20090149623 Nitrogenated aromatic compound, process for production of the same, polymer, and proton conductive membrane |
| 06/11/2009 | US20090149523 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases |
| 06/11/2009 | US20090149474 tert-butyl 4-[(4-chlorobenzoyl)amino]-2-(dimethylamino)-1-phenyl-1H-imidazole-5-carboxylate, used for the treatment of gastrointestinal disorders such as gastroesophageal reflux, irritable bowel syndrome, dyspepsia, diarrhea and for the inhibition of transient lower esophageal sphincter relaxations |